menu search

UBS / TRIANA Biomedicines to Present at UBS Biotechnology Private Company Virtual Symposium

TRIANA Biomedicines to Present at UBS Biotechnology Private Company Virtual Symposium
LEXINGTON, MA / ACCESSWIRE / September 18, 2023 / TRIANA Biomedicines, Inc. (TRIANA), an innovative biopharmaceutical company focused on advancing a target-first and rational molecular glue discovery platform to address difficult to drug disease targets, today announced that Dr. Patrick Trojer, President and Chief Executive Officer, will present at the UBS Biotechnology Private Company Virtual Symposium on Wednesday September 20, 2023 at 3:30 PM ET. About TRIANA Biomedicines, Inc. TRIANA Biomedicines is a private biotechnology company, headquartered in Lexington, Massachusetts and focused on building the leading molecular glue discovery platform to regulate disease targets that are difficult to address with any other modality. Read More
Posted: Sep 18 2023, 07:30
Author Name: Accesswire
Views: 041344

UBS News  

Ex-UBS Chairman Weber: Fed Likely to Hike Rates in December

By Bloomberg Markets and Finance
November 2, 2023

Ex-UBS Chairman Weber: Fed Likely to Hike Rates in December

Axel Weber, former chairman of UBS who was also president of the German Bundesbank, discusses the policies of the Federal Reserve and the European Cen more_horizontal

UBS slashes lithium demand forecast

By Proactive Investors
November 1, 2023

UBS slashes lithium demand forecast

Analysts at UBS have reduced their forecast for lithium demand due to an anticipated slump in appetite for electric vehicles, according to a research more_horizontal

Credit Suisse intervention avoided 'financial crisis,' Swiss National Bank chairman says

By CNBC
November 1, 2023

Credit Suisse intervention avoided 'financial crisis,' Swiss National Bank chairman says

Swiss National Bank Chairman Thomas Jordan said the central bank's interventions during the fall of Credit Suisse were "crucial" to avoid a "financial more_horizontal

BT a potential beneficiary from ESG trends, suggests UBS

By Proactive Investors
November 1, 2023

BT a potential beneficiary from ESG trends, suggests UBS

BT stands to emerge as an unlikely winner from the current trends in ESG across the telecoms sector, according to analysts at UBS, though the bank's s more_horizontal

The bears clearly have been in control of the market, says UBS' Jason Katz

By CNBC Television
October 25, 2023

The bears clearly have been in control of the market, says UBS' Jason Katz

Jason Katz of UBS' Katz Wealth Management discusses the trading day ahead and where he's finding opportunity. more_horizontal

China's Latest Stimulus 'Very Positive' for Markets; UBS

By Bloomberg Markets and Finance
October 24, 2023

China's Latest Stimulus 'Very Positive' for Markets; UBS

Yifan Hu, regional chief investment officer and head of Asia Pacific macroeconomics at UBS Global Wealth Management, discusses China's efforts to boos more_horizontal

'The bond vigilante is coming back,' UBS strategist says

By CNBC
October 23, 2023

'The bond vigilante is coming back,' UBS strategist says

The "bond vigilantes are coming back" as investors continue to sell amid the prospect of a growing fiscal deficit, according to UBS Asset Management's more_horizontal

AI Will Help Retail Sales, Says UBS. Here's How.

By Barrons
October 20, 2023

AI Will Help Retail Sales, Says UBS. Here's How.

Retailers that adopt artificial-intelligence initiatives could see outsize stock performance, says analyst Jay Sole. more_horizontal


Search within

Pages Search Results: